Papers
2
Total Citations
11
H-Index
2
About
Robert Valesky is a bioanalytical chemist whose work has advanced the quantification of therapeutic compounds in human plasma, particularly through the application of high-throughput mass spectrometry and radioactivity detection. His most-cited research, an automated enzyme inhibition assay for atorvastatin-derived HMG-CoA reductase inhibitors, demonstrates a key contribution to pharmacokinetic analysis, enabling precise measurement of statin activity in biological samples. This method, cited 9 times, underscores his expertise in bridging enzymatic assays with clinical drug monitoring. Valesky also developed a flexible, high-throughput liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for telcagepant, a migraine therapeutic, achieving robust quantitation with minimal sample preparation. Though his citation counts are modest, his work reflects a focus on practical, reproducible bioanalytical tools that support drug development and therapeutic drug monitoring. His contributions are particularly valuable for researchers seeking validated, efficient protocols for plasma analysis, highlighting his role in refining the analytical backbone of modern pharmacology.
Research Focus
Key Achievements
Top Papers
- 1
- 2